123 related articles for article (PubMed ID: 10713336)
1. Sequence analyses of feline B7 costimulatory molecules.
Choi IS; Hash SM; Winslow BJ; Collisson EW
Vet Immunol Immunopathol; 2000 Mar; 73(3-4):219-31. PubMed ID: 10713336
[TBL] [Abstract][Full Text] [Related]
2. Novel transcripts encoding secreted forms of feline CD80 and CD86 costimulatory molecules.
Yang S; Sellins KS; Powell T; Stoneman E; Sim GK
Vet Immunol Immunopathol; 2001 Aug; 81(1-2):15-21. PubMed ID: 11498243
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig.
Nishimura Y; Shimojima M; Miyazawa T; Sato E; Nakamura K; Izumiya Y; Ikeda Y; Mikami T; Takahashi E
Eur J Immunogenet; 2000; 27(5-6):427-30. PubMed ID: 11029611
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).
Jellis CL; Wang SS; Rennert P; Borriello F; Sharpe AH; Green NR; Gray GS
Immunogenetics; 1995; 42(2):85-9. PubMed ID: 7541777
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rat CD80 and CD86 by molecular cloning and mAb.
Maeda K; Sato T; Azuma M; Yagita H; Okumura K
Int Immunol; 1997 Jul; 9(7):993-1000. PubMed ID: 9237108
[TBL] [Abstract][Full Text] [Related]
6. New forms of dog CD80 and CD86 transcripts that encode secreted B7 molecules.
Yang S; Sim GK
Immunogenetics; 1999 Dec; 50(5-6):349-53. PubMed ID: 10630300
[No Abstract] [Full Text] [Related]
7. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
8. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS
J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis.
Summers KL; O'Donnell JL; Williams LA; Hart DN
Arthritis Rheum; 1996 Aug; 39(8):1287-91. PubMed ID: 8702435
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2).
Zhang D; Johnson RP
Cell Immunol; 1997 Apr; 177(1):9-17. PubMed ID: 9140091
[TBL] [Abstract][Full Text] [Related]
12. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and expression of feline CD28 and CTLA-4 cDNA.
Choi IS; Hash SM; Collisson EW
Vet Immunol Immunopathol; 2000 Aug; 76(1-2):45-59. PubMed ID: 10973685
[TBL] [Abstract][Full Text] [Related]
14. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens.
Wroblewski JM; Bixby DL; Borowski C; Yannelli JR
Lung Cancer; 2001; 33(2-3):181-94. PubMed ID: 11551413
[TBL] [Abstract][Full Text] [Related]
16. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
[TBL] [Abstract][Full Text] [Related]
17. Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells.
Luque I; Reyburn H; Strominger JL
Hum Immunol; 2000 Aug; 61(8):721-8. PubMed ID: 10980383
[TBL] [Abstract][Full Text] [Related]
18. CD80 (B7-1) and CD86 (B7-2) genes and genetic susceptibility to coeliac disease.
Woolley N; Holopainen P; Bourgain C; Mustalahti K; Collin P; Mäki M; Partanen J
Eur J Immunogenet; 2002 Aug; 29(4):331-3. PubMed ID: 12121279
[TBL] [Abstract][Full Text] [Related]
19. Glomerular endothelium exhibits enhanced expression of costimulatory adhesion molecules, CD80 and CD86, by warm ischemia/reperfusion injury in rats.
Satoh S; Suzuki A; Asari Y; Sato M; Kojima N; Sato T; Tsuchiya N; Sato K; Senoo H; Kato T
Lab Invest; 2002 Sep; 82(9):1209-17. PubMed ID: 12218082
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
